Werbung
Werbung
VNRX
VolitionRX Limited Common Stock
0.34
USDGesponsert
-0.02
-5.58%
09. Jan., 15:55 UTC -5
Geschlossen
Nach-Markt
0.33
-0.01
-1.79%
VNRX Ergebnisberichte
Positives Überraschungsverhältnis
VNRX übertreffen die 24 der letzten 40Schätzungen.
60%
Nächster Bericht
Datum des nächsten Berichts
30. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$780.47K
/-$0.04
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+24.42%
/-20.00%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+306.50%
/-33.33%
VolitionRX Limited Common Stock earnings per share and revenue
On 13. Nov. 2025, VNRX reported earnings of -0.05 USD per share (EPS) for Q3 25, missing the estimate of -0.04 USD, resulting in a -11.36% surprise. Revenue reached 627.28 tausend, compared to an expected 1.71 million, with a -63.41% difference. The market reacted with a -6.60% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of -0.04 USD, with revenue projected to reach 780.47 tausend USD, implying an decrease of -20.00% EPS, and increase of 24.42% in Revenue from the last quarter.
FAQ
What were VolitionRX Limited Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, VolitionRX Limited Common Stock reported EPS of -$0.05, missing estimates by -11.36%, and revenue of $627.28K, -63.41% below expectations.
How did the market react to VolitionRX Limited Common Stock's Q3 2025 earnings?
The stock price moved down -6.6%, changed from $0.35 before the earnings release to $0.33 the day after.
When is VolitionRX Limited Common Stock expected to report next?
The next earning report is scheduled for 30. März 2026.
What are the forecasts for VolitionRX Limited Common Stock's next earnings report?
Based on 8
analysts, VolitionRX Limited Common Stock is expected to report EPS of -$0.04 and revenue of $780.47K for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung